Name | 2-[[2-[[2-[[1-[2-(2,6-diaminohexanoylamino)-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-4-methylpentanoic acid |
---|---|
Synonyms |
neuromedin N
Lys-ile-pro-tyr-ile-leu |
Description | Neuromedin N is a potent modulator of dopamine D2 receptor agonist binding in rat neostriatal membranes. Sequence: Lys-Ile-Pro-Tyr-Ile-Leu. |
---|---|
Related Catalog | |
Target |
Dopamine D2 receptor[1]. |
In Vitro | Neuromedin N competitively inhibits the binding of neurotensin to rat brain synaptic membranes with a 19-fold lower potency than neurotensin and is rapidly inactivated by brain synaptic peptidases[1]. It competitively inhibits neurotensin binding to rat brain synaptic membranes and has increased potency in the presence of the peptidase inhibitor bestatin[2]. |
References |
Molecular Formula | C38H63N7O8 |
---|---|
Molecular Weight | 745.94900 |
Exact Mass | 745.47400 |
PSA | 246.28000 |
LogP | 4.44620 |
Storage condition | -20°C |
~%
Detail
|
Literature: Kiso; Kimura; Fujiwara; Sakikawa; Akaji Chemical and Pharmaceutical Bulletin, 1990 , vol. 38, # 1 p. 270 - 272 |
Precursor 3 | |
---|---|
DownStream 0 |